Author
Listed:
- Paul C. Tumeh
(University of California Los Angeles (UCLA)
Jonsson Comprehensive Cancer Center)
- Christina L. Harview
(University of California Los Angeles (UCLA))
- Jennifer H. Yearley
(Merck & Co)
- I. Peter Shintaku
(University of California Los Angeles (UCLA))
- Emma J. M. Taylor
(University of California Los Angeles (UCLA))
- Lidia Robert
(University of California Los Angeles (UCLA))
- Bartosz Chmielowski
(University of California Los Angeles (UCLA)
Jonsson Comprehensive Cancer Center)
- Marko Spasic
(University of California Los Angeles (UCLA))
- Gina Henry
(University of California Los Angeles (UCLA))
- Voicu Ciobanu
(University of California Los Angeles (UCLA))
- Alisha N. West
(University of California Los Angeles (UCLA))
- Manuel Carmona
(University of California Los Angeles (UCLA))
- Christine Kivork
(University of California Los Angeles (UCLA))
- Elizabeth Seja
(University of California Los Angeles (UCLA))
- Grace Cherry
(University of California Los Angeles (UCLA))
- Antonio J. Gutierrez
(University of California Los Angeles (UCLA))
- Tristan R. Grogan
(University of California Los Angeles (UCLA))
- Christine Mateus
(Gustave Roussy and INSERM U981, Villejuif, Paris Sud, France)
- Gorana Tomasic
(Gustave Roussy and INSERM U981, Villejuif, Paris Sud, France)
- John A. Glaspy
(University of California Los Angeles (UCLA)
Jonsson Comprehensive Cancer Center)
- Ryan O. Emerson
(Adaptive Biotechnologies)
- Harlan Robins
(Adaptive Biotechnologies
Fred Hutchinson Cancer Research Center)
- Robert H. Pierce
(Merck & Co)
- David A. Elashoff
(University of California Los Angeles (UCLA)
Jonsson Comprehensive Cancer Center)
- Caroline Robert
(Gustave Roussy and INSERM U981, Villejuif, Paris Sud, France)
- Antoni Ribas
(University of California Los Angeles (UCLA)
Jonsson Comprehensive Cancer Center)
Abstract
The dynamics of T-cell responses are investigated in tumour tissue from patients with advanced melanoma who were treated with a PD-1-blocking monoclonal antibody, revealing that clinical efficacy of the treatment correlates with increased frequencies of pre-existing CD8+ T cells and PD-1 and PD-L1 expression.
Suggested Citation
Paul C. Tumeh & Christina L. Harview & Jennifer H. Yearley & I. Peter Shintaku & Emma J. M. Taylor & Lidia Robert & Bartosz Chmielowski & Marko Spasic & Gina Henry & Voicu Ciobanu & Alisha N. West & M, 2014.
"PD-1 blockade induces responses by inhibiting adaptive immune resistance,"
Nature, Nature, vol. 515(7528), pages 568-571, November.
Handle:
RePEc:nat:nature:v:515:y:2014:i:7528:d:10.1038_nature13954
DOI: 10.1038/nature13954
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:515:y:2014:i:7528:d:10.1038_nature13954. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.